If 2 or more consecutive doses are missed, resume dosing as scheduled or, if needed, reinitiate Wegovy and follow the dose escalation schedule, which may reduce the occurrence of gastrointestinal symptoms associated with reinitiation of treatment
According to a 2024 survey by Morgan Stanley Research, 59% of individuals on anti-obesity medication are drinking more tap or still water, 66% are consuming less soda and alcohol, and 38% are increasing their intake of protein beverages
The findings, presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey, come from a large real-world analysis led by Professor John Wilding of the University of Liverpool in the UK
Gastrointestinal issues like nausea, vomiting, diarrhea, stomach pain, and constipation are common symptoms experienced by people taking semaglutide, with these side effects most pronounced during dose escalation
Acetyl-L-carnitine (ALCA) fed to aged rats was shown to reverse age-related declines in tissue L-carnitine levels and also reversed a number of age-related changes in liver mitochondrial function